Epigenetic reprogramming biotech using transcription factors to restore youthful gene expression in aging cells, starting with the liver.
Develops partial epigenetic reprogramming medicines using OSK transcription factors to restore aged cells toward a younger state.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →